192 related articles for article (PubMed ID: 11249554)
1. Levofloxacin.
Norrby SR
Expert Opin Pharmacother; 1999 Nov; 1(1):109-19. PubMed ID: 11249554
[TBL] [Abstract][Full Text] [Related]
2. Levofloxacin and trovafloxacin: the next generation of fluoroquinolones?
Ernst ME; Ernst EJ; Klepser ME
Am J Health Syst Pharm; 1997 Nov; 54(22):2569-84. PubMed ID: 9397218
[TBL] [Abstract][Full Text] [Related]
3. Levofloxacin, a second-generation fluoroquinolone.
North DS; Fish DN; Redington JJ
Pharmacotherapy; 1998; 18(5):915-35. PubMed ID: 9758306
[TBL] [Abstract][Full Text] [Related]
4. Levofloxacin: a therapeutic review.
Wimer SM; Schoonover L; Garrison MW
Clin Ther; 1998; 20(6):1049-70. PubMed ID: 9916602
[TBL] [Abstract][Full Text] [Related]
5. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
Croom KF; Goa KL
Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
[TBL] [Abstract][Full Text] [Related]
6. [Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)].
Scheen AJ
Rev Med Liege; 2000 Nov; 55(11):1015-7. PubMed ID: 11195704
[TBL] [Abstract][Full Text] [Related]
7. A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections.
Martin SJ; Jung R; Garvin CG
Drug Saf; 2001; 24(3):199-222. PubMed ID: 11347723
[TBL] [Abstract][Full Text] [Related]
8. Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract.
Langtry HD; Lamb HM
Drugs; 1998 Sep; 56(3):487-515. PubMed ID: 9777318
[TBL] [Abstract][Full Text] [Related]
9. Levofloxacin: an updated review of its use in the treatment of bacterial infections.
Hurst M; Lamb HM; Scott LJ; Figgitt DP
Drugs; 2002; 62(14):2127-67. PubMed ID: 12269858
[TBL] [Abstract][Full Text] [Related]
10. Levofloxacin and sparfloxacin: new quinolone antibiotics.
Martin SJ; Meyer JM; Chuck SK; Jung R; Messick CR; Pendland SL
Ann Pharmacother; 1998 Mar; 32(3):320-36. PubMed ID: 9533064
[TBL] [Abstract][Full Text] [Related]
11. Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy.
Davis R; Bryson HM
Drugs; 1994 Apr; 47(4):677-700. PubMed ID: 7516863
[TBL] [Abstract][Full Text] [Related]
12. The clinical pharmacokinetics of levofloxacin.
Fish DN; Chow AT
Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
[TBL] [Abstract][Full Text] [Related]
13. New fluoroquinolone antibiotics.
Drug Ther Bull; 1999 Jan; 37(1):6-8. PubMed ID: 10562769
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapeutic activity of levofloxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animals.
Klesel N; Geweniger KH; Koletzki P; Isert D; Limbert M; Markus A; Riess G; Schramm H; Iyer P
J Antimicrob Chemother; 1995 Jun; 35(6):805-19. PubMed ID: 7559192
[TBL] [Abstract][Full Text] [Related]
15. [The first 'respiration' fluoroquinolone--levofloxacin (Tavanic) in therapy of bacterial infections. Pharmacodynamics principles in optimization of administration regimens].
Budanov SV; Vasil'ev AN; Smirnova LB
Antibiot Khimioter; 2001; 46(7):38-46. PubMed ID: 11697244
[No Abstract] [Full Text] [Related]
16. Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin, and DU-6859a) in the treatment of anaerobic infections: review of current information on efficacy and safety.
Goldstein EJ
Clin Infect Dis; 1996 Dec; 23 Suppl 1():S25-30. PubMed ID: 8953103
[TBL] [Abstract][Full Text] [Related]
17. A critical review of the fluoroquinolones: focus on respiratory infections.
Zhanel GG; Ennis K; Vercaigne L; Walkty A; Gin AS; Embil J; Smith H; Hoban DJ
Drugs; 2002; 62(1):13-59. PubMed ID: 11790155
[TBL] [Abstract][Full Text] [Related]
18. Latest industry information on the safety profile of levofloxacin in Japan.
Yagawa K
Chemotherapy; 2001; 47 Suppl 3():38-43; discussion 44-8. PubMed ID: 11549788
[TBL] [Abstract][Full Text] [Related]
19. Levofloxacin : a review of its use as a high-dose, short-course treatment for bacterial infection.
Anderson VR; Perry CM
Drugs; 2008; 68(4):535-65. PubMed ID: 18318569
[TBL] [Abstract][Full Text] [Related]
20. Sparfloxacin and levofloxacin.
Med Lett Drugs Ther; 1997 Apr; 39(999):41-3. PubMed ID: 9137295
[No Abstract] [Full Text] [Related]
[Next] [New Search]
